Exact Mass: 525.4393004

Exact Mass Matches: 525.4393004

Found 181 metabolites which its exact mass value is equals to given mass value 525.4393004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

ICI 164384

ICI 164384; N-n-Butyl-N-methyl-11-[3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl]undecanamide

C34H55NO3 (525.418172)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

19-Methyltetracosanoylcarnitine

3-[(19-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


19-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 19-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 19-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 19-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Methyltetracosanoylcarnitine

3-[(7-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


7-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 7-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 7-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

20-Methyltetracosanoylcarnitine

3-[(20-Methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C32H63NO4 (525.4756838000001)


20-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 20-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 20-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 20-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methyltetracosanoylcarnitine

3-[(3-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


3-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 3-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Methyltetracosanoylcarnitine

3-[(9-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


9-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 9-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 9-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

15-Methyltetracosanoylcarnitine

3-[(15-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


15-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 15-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 15-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 15-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

23-Methyltetracosanoylcarnitine

3-[(23-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


23-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 23-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 23-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 23-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

16-Methyltetracosanoylcarnitine

3-[(16-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


16-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 16-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 16-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 16-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

13-Methyltetracosanoylcarnitine

3-[(13-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


13-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 13-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 13-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 13-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-Methyltetracosanoylcarnitine

3-[(10-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


10-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 10-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 10-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 10-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

17-Methyltetracosanoylcarnitine

3-[(17-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


17-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 17-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 17-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 17-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

21-Methyltetracosanoylcarnitine

3-[(21-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


21-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 21-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 21-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 21-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

22-Methyltetracosanoylcarnitine

3-[(22-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


22-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 22-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 22-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 22-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methyltetracosanoylcarnitine

3-[(5-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


5-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 5-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

14-Methyltetracosanoylcarnitine

3-[(14-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


14-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 14-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 14-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 14-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Methyltetracosanoylcarnitine

3-[(8-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


8-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 8-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 8-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Methyltetracosanoylcarnitine

3-[(6-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


6-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 6-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 6-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Methyltetracosanoylcarnitine

3-[(4-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


4-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 4-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

18-Methyltetracosanoylcarnitine

3-[(18-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


18-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 18-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 18-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 18-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

11-Methyltetracosanoylcarnitine

3-[(11-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


11-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 11-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 11-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 11-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

12-Methyltetracosanoylcarnitine

3-[(12-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


12-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 12-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 12-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 12-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Pentacosanoylcarnitine

3-(pentacosanoyloxy)-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4756838000001)


Pentacosanoylcarnitine is an acylcarnitine. More specifically, it is an pentacosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Pentacosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine Pentacosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide

N-butyl-11-{5,14-dihydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-9-yl}-N-methylundecanamide

C34H55NO3 (525.418172)


   

O2-Hexadecanoyl-3-Methyl-2-[6-(3-methyl-2-butenyl)-1H-indol-3-yl]-1,3-butanediol

O2-Hexadecanoyl-3-Methyl-2-[6-(3-methyl-2-butenyl)-1H-indol-3-yl]-1,3-butanediol

C34H55NO3 (525.418172)


   

Cer 32:1;O3

N-(tetradecanoyl)-6R-hydroxy-sphing-4E-enine

C32H63NO4 (525.4756838000001)


   

Cer[AS]

N-(2-hydroxy-tetradecanoyl)-sphing-4-enine

C32H63NO4 (525.4756838000001)


   

PEG-5 STEARYL AMMONIUM CHLORIDE

PEG-5 STEARYL AMMONIUM CHLORIDE

C28H60ClNO5 (525.415978)


   

N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide

N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide

C34H55NO3 (525.418172)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide

N-butyl-11-{5,14-dihydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-9-yl}-N-methylundecanamide

C34H55NO3 (525.418172)


   
   
   
   
   
   
   
   
   

19-Methyltetracosanoylcarnitine

19-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

20-Methyltetracosanoylcarnitine

20-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

15-Methyltetracosanoylcarnitine

15-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

23-Methyltetracosanoylcarnitine

23-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

16-Methyltetracosanoylcarnitine

16-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

13-Methyltetracosanoylcarnitine

13-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

10-Methyltetracosanoylcarnitine

10-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

17-Methyltetracosanoylcarnitine

17-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

21-Methyltetracosanoylcarnitine

21-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

22-Methyltetracosanoylcarnitine

22-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

14-Methyltetracosanoylcarnitine

14-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

18-Methyltetracosanoylcarnitine

18-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

11-Methyltetracosanoylcarnitine

11-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

12-Methyltetracosanoylcarnitine

12-Methyltetracosanoylcarnitine

C32H63NO4 (525.4756838000001)


   

(21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoate

(21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoate

C36H61O2- (525.4671306)


A hexatriacontapentaenoate that is the conjugate base of (21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoate

(18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoate

C36H61O2- (525.4671306)


A polyunsaturated fatty acid anion that is the conjugate base of (18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   
   
   
   
   
   
   
   
   
   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-(1,3-dihydroxyoctan-2-yl)hexacosa-5,8,11,14,17,20,23-heptaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-(1,3-dihydroxyoctan-2-yl)hexacosa-5,8,11,14,17,20,23-heptaenamide

C34H55NO3 (525.418172)


   

(8Z,11Z,14Z,17Z,20Z,23Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]hexacosa-8,11,14,17,20,23-hexaenamide

(8Z,11Z,14Z,17Z,20Z,23Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]hexacosa-8,11,14,17,20,23-hexaenamide

C34H55NO3 (525.418172)


   

(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide

(7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]docosa-7,10,13,16,19-pentaenamide

C34H55NO3 (525.418172)


   

(5Z,8Z,11Z,14Z,17Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]icosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]icosa-5,8,11,14,17-pentaenamide

C34H55NO3 (525.418172)


   

(8Z,11Z,14Z,17Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]icosa-8,11,14,17-tetraenamide

(8Z,11Z,14Z,17Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]icosa-8,11,14,17-tetraenamide

C34H55NO3 (525.418172)


   

(6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]octadeca-6,9,12,15-tetraenamide

(6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]octadeca-6,9,12,15-tetraenamide

C34H55NO3 (525.418172)


   

(4Z,7Z,10Z,13Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]hexadeca-4,7,10,13-tetraenamide

C34H55NO3 (525.418172)


   

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

C34H55NO3 (525.418172)


   

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide

C34H55NO3 (525.418172)


   

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide

C34H55NO3 (525.418172)


   

Cer 9:0;3O/22:2;(2OH)

Cer 9:0;3O/22:2;(2OH)

C31H59NO5 (525.4393004)


   

Cer 11:0;3O/20:2;(2OH)

Cer 11:0;3O/20:2;(2OH)

C31H59NO5 (525.4393004)


   

Cer 13:0;3O/18:2;(2OH)

Cer 13:0;3O/18:2;(2OH)

C31H59NO5 (525.4393004)


   

Cer 13:1;3O/18:1;(2OH)

Cer 13:1;3O/18:1;(2OH)

C31H59NO5 (525.4393004)


   

Cer 12:1;3O/19:1;(2OH)

Cer 12:1;3O/19:1;(2OH)

C31H59NO5 (525.4393004)


   
   

N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]heptadecanamide

N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]heptadecanamide

C32H63NO4 (525.4756838000001)


   

N-[(E)-1,3,4-trihydroxyicos-8-en-2-yl]dodecanamide

N-[(E)-1,3,4-trihydroxyicos-8-en-2-yl]dodecanamide

C32H63NO4 (525.4756838000001)


   

N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]tetradecanamide

N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]tetradecanamide

C32H63NO4 (525.4756838000001)


   

(Z)-N-(1,3,4-trihydroxyheptadecan-2-yl)pentadec-9-enamide

(Z)-N-(1,3,4-trihydroxyheptadecan-2-yl)pentadec-9-enamide

C32H63NO4 (525.4756838000001)


   

N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]pentadecanamide

N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]pentadecanamide

C32H63NO4 (525.4756838000001)


   

(Z)-N-(1,3,4-trihydroxyhexadecan-2-yl)hexadec-7-enamide

(Z)-N-(1,3,4-trihydroxyhexadecan-2-yl)hexadec-7-enamide

C32H63NO4 (525.4756838000001)


   

(Z)-N-(1,3,4-trihydroxytetradecan-2-yl)octadec-11-enamide

(Z)-N-(1,3,4-trihydroxytetradecan-2-yl)octadec-11-enamide

C32H63NO4 (525.4756838000001)


   

(Z)-N-(1,3,4-trihydroxyicosan-2-yl)dodec-5-enamide

(Z)-N-(1,3,4-trihydroxyicosan-2-yl)dodec-5-enamide

C32H63NO4 (525.4756838000001)


   

(Z)-N-(1,3,4-trihydroxynonadecan-2-yl)tridec-8-enamide

(Z)-N-(1,3,4-trihydroxynonadecan-2-yl)tridec-8-enamide

C32H63NO4 (525.4756838000001)


   

N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]octadecanamide

N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]octadecanamide

C32H63NO4 (525.4756838000001)


   

(Z)-N-(1,3,4-trihydroxyoctadecan-2-yl)tetradec-9-enamide

(Z)-N-(1,3,4-trihydroxyoctadecan-2-yl)tetradec-9-enamide

C32H63NO4 (525.4756838000001)


   

N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]hexadecanamide

N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]hexadecanamide

C32H63NO4 (525.4756838000001)


   

N-[(E)-1,3,4-trihydroxynonadec-8-en-2-yl]tridecanamide

N-[(E)-1,3,4-trihydroxynonadec-8-en-2-yl]tridecanamide

C32H63NO4 (525.4756838000001)


   
   
   
   
   
   

Cer 19:2;3O/12:0;(2OH)

Cer 19:2;3O/12:0;(2OH)

C31H59NO5 (525.4393004)


   

Cer 14:2;3O/17:0;(2OH)

Cer 14:2;3O/17:0;(2OH)

C31H59NO5 (525.4393004)


   
   
   
   

Cer 17:1;3O/14:1;(2OH)

Cer 17:1;3O/14:1;(2OH)

C31H59NO5 (525.4393004)


   

Cer 17:2;3O/14:0;(2OH)

Cer 17:2;3O/14:0;(2OH)

C31H59NO5 (525.4393004)


   

Cer 18:2;3O/13:0;(2OH)

Cer 18:2;3O/13:0;(2OH)

C31H59NO5 (525.4393004)


   
   
   

Cer 18:1;3O/13:1;(2OH)

Cer 18:1;3O/13:1;(2OH)

C31H59NO5 (525.4393004)


   

Cer 16:2;3O/15:0;(2OH)

Cer 16:2;3O/15:0;(2OH)

C31H59NO5 (525.4393004)


   

Cer 19:1;3O/12:1;(2OH)

Cer 19:1;3O/12:1;(2OH)

C31H59NO5 (525.4393004)


   
   

Cer 15:2;3O/16:0;(2OH)

Cer 15:2;3O/16:0;(2OH)

C31H59NO5 (525.4393004)


   
   
   

Cer 15:1;3O/16:1;(2OH)

Cer 15:1;3O/16:1;(2OH)

C31H59NO5 (525.4393004)


   

Cer 15:0;3O/16:2;(2OH)

Cer 15:0;3O/16:2;(2OH)

C31H59NO5 (525.4393004)


   
   
   
   

Cer 16:1;3O/15:1;(2OH)

Cer 16:1;3O/15:1;(2OH)

C31H59NO5 (525.4393004)


   
   
   
   
   
   
   
   
   
   
   
   

hexatriacontapentaenoate

hexatriacontapentaenoate

C36H61O2 (525.4671306)


A polyunsaturated fatty acid anion that is the conjugate base of hexatriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(2s)-3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

(2s)-3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

C34H55NO3 (525.418172)


   

(2s)-3-hydroxy-3-methyl-2-[5-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

(2s)-3-hydroxy-3-methyl-2-[5-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

C34H55NO3 (525.418172)


   

3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

C34H55NO3 (525.418172)


   

3-hydroxy-3-methyl-2-[5-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

3-hydroxy-3-methyl-2-[5-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

C34H55NO3 (525.418172)


   

(2r)-3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

(2r)-3-hydroxy-3-methyl-2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]butyl hexadecanoate

C34H55NO3 (525.418172)